Loading…

A case of chronic inflammatory demyelinating polyneuropathy following COVID‐19 vaccine

We report a 44‐year‐old woman who presented with bilateral weakness of the hands and distal paresthesia of the arms on the next day of the second COVID‐19 vaccine, and gradually progressed ascending weakness of the arms and legs, and sensory ataxia beyond 2 months. She was diagnosed as a chronic inf...

Full description

Saved in:
Bibliographic Details
Published in:Neurology and clinical neuroscience 2022-07, Vol.10 (4), p.223-225
Main Authors: Katada, Eiichi, Toyoda, Takanari, Yamada, Gohei, Morishima, Akira, Matsukawa, Noriyuki
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c5054-249f73d31ca28e529b313dd97b3976cbb357ae7977bd0432a147cc15a66777473
cites cdi_FETCH-LOGICAL-c5054-249f73d31ca28e529b313dd97b3976cbb357ae7977bd0432a147cc15a66777473
container_end_page 225
container_issue 4
container_start_page 223
container_title Neurology and clinical neuroscience
container_volume 10
creator Katada, Eiichi
Toyoda, Takanari
Yamada, Gohei
Morishima, Akira
Matsukawa, Noriyuki
description We report a 44‐year‐old woman who presented with bilateral weakness of the hands and distal paresthesia of the arms on the next day of the second COVID‐19 vaccine, and gradually progressed ascending weakness of the arms and legs, and sensory ataxia beyond 2 months. She was diagnosed as a chronic inflammatory demyelinating polyneuropathy (CIDP) following COVID‐19 vaccine on the basis of clinical and electrophysiological findings. This is a first case diagnosed as a CIDP following COVID‐19 vaccine alone.
doi_str_mv 10.1111/ncn3.12604
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9115276</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2685867607</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5054-249f73d31ca28e529b313dd97b3976cbb357ae7977bd0432a147cc15a66777473</originalsourceid><addsrcrecordid>eNp9kc9KAzEQh4MottRefABZ8Ca0Jpts0lyEUv8VSntR8Ray2WybspvU7LZlbz6Cz-iTuGtr0YtzSWA-vhnmB8A5gn1U17VVFvdRSCE5Au0QEt4jiOHjX_8W6BbFEtbFOUZ8cApaOKIQEYLb4HUYKFnowKWBWnhnjQqMTTOZ57J0vgoSnVc6M1aWxs6Dlcsqq9ferWS5qILUZZnbNo3R7GV8-_n-gXiwkUoZq8_ASSqzQnf3bwc83989jR57k9nDeDSc9FQEI9ILCU8ZTjBSMhzoKOQxRjhJOIsxZ1TFMY6Y1IwzFieQ4FAiwpRCkaSUMUYY7oCbnXe1jnOdKG1LLzOx8iaXvhJOGvG3Y81CzN1GcISikNFacLkXePe21kUplm7tbb2zCOkgGlBGYTPmakcp74rC6_QwAUHRBCGaIMR3EDV88XunA_pz9hpAO2BrMl39oxLT0RTvpF9vY5Ob</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2685867607</pqid></control><display><type>article</type><title>A case of chronic inflammatory demyelinating polyneuropathy following COVID‐19 vaccine</title><source>Wiley-Blackwell Read &amp; Publish Collection</source><creator>Katada, Eiichi ; Toyoda, Takanari ; Yamada, Gohei ; Morishima, Akira ; Matsukawa, Noriyuki</creator><creatorcontrib>Katada, Eiichi ; Toyoda, Takanari ; Yamada, Gohei ; Morishima, Akira ; Matsukawa, Noriyuki</creatorcontrib><description>We report a 44‐year‐old woman who presented with bilateral weakness of the hands and distal paresthesia of the arms on the next day of the second COVID‐19 vaccine, and gradually progressed ascending weakness of the arms and legs, and sensory ataxia beyond 2 months. She was diagnosed as a chronic inflammatory demyelinating polyneuropathy (CIDP) following COVID‐19 vaccine on the basis of clinical and electrophysiological findings. This is a first case diagnosed as a CIDP following COVID‐19 vaccine alone.</description><identifier>ISSN: 2049-4173</identifier><identifier>EISSN: 2049-4173</identifier><identifier>DOI: 10.1111/ncn3.12604</identifier><identifier>PMID: 35601443</identifier><language>eng</language><publisher>England: Wiley Subscription Services, Inc</publisher><subject>Ataxia ; Case Report ; chronic inflammatory demyelinating polyneuropathy ; COVID-19 ; COVID‐19 vaccine ; Demyelination ; Guillain–Barrẻ syndrome ; Inflammation ; Paresthesia ; Polyneuropathy ; Vaccines</subject><ispartof>Neurology and clinical neuroscience, 2022-07, Vol.10 (4), p.223-225</ispartof><rights>2022 Japanese Society of Neurology and John Wiley &amp; Sons Australia, Ltd.</rights><rights>2022 Japanese Society of Neurology and John Wiley &amp; Sons Australia, Ltd</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5054-249f73d31ca28e529b313dd97b3976cbb357ae7977bd0432a147cc15a66777473</citedby><cites>FETCH-LOGICAL-c5054-249f73d31ca28e529b313dd97b3976cbb357ae7977bd0432a147cc15a66777473</cites><orcidid>0000-0002-1594-5141</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35601443$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Katada, Eiichi</creatorcontrib><creatorcontrib>Toyoda, Takanari</creatorcontrib><creatorcontrib>Yamada, Gohei</creatorcontrib><creatorcontrib>Morishima, Akira</creatorcontrib><creatorcontrib>Matsukawa, Noriyuki</creatorcontrib><title>A case of chronic inflammatory demyelinating polyneuropathy following COVID‐19 vaccine</title><title>Neurology and clinical neuroscience</title><addtitle>Neurol Clin Neurosci</addtitle><description>We report a 44‐year‐old woman who presented with bilateral weakness of the hands and distal paresthesia of the arms on the next day of the second COVID‐19 vaccine, and gradually progressed ascending weakness of the arms and legs, and sensory ataxia beyond 2 months. She was diagnosed as a chronic inflammatory demyelinating polyneuropathy (CIDP) following COVID‐19 vaccine on the basis of clinical and electrophysiological findings. This is a first case diagnosed as a CIDP following COVID‐19 vaccine alone.</description><subject>Ataxia</subject><subject>Case Report</subject><subject>chronic inflammatory demyelinating polyneuropathy</subject><subject>COVID-19</subject><subject>COVID‐19 vaccine</subject><subject>Demyelination</subject><subject>Guillain–Barrẻ syndrome</subject><subject>Inflammation</subject><subject>Paresthesia</subject><subject>Polyneuropathy</subject><subject>Vaccines</subject><issn>2049-4173</issn><issn>2049-4173</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNp9kc9KAzEQh4MottRefABZ8Ca0Jpts0lyEUv8VSntR8Ray2WybspvU7LZlbz6Cz-iTuGtr0YtzSWA-vhnmB8A5gn1U17VVFvdRSCE5Au0QEt4jiOHjX_8W6BbFEtbFOUZ8cApaOKIQEYLb4HUYKFnowKWBWnhnjQqMTTOZ57J0vgoSnVc6M1aWxs6Dlcsqq9ferWS5qILUZZnbNo3R7GV8-_n-gXiwkUoZq8_ASSqzQnf3bwc83989jR57k9nDeDSc9FQEI9ILCU8ZTjBSMhzoKOQxRjhJOIsxZ1TFMY6Y1IwzFieQ4FAiwpRCkaSUMUYY7oCbnXe1jnOdKG1LLzOx8iaXvhJOGvG3Y81CzN1GcISikNFacLkXePe21kUplm7tbb2zCOkgGlBGYTPmakcp74rC6_QwAUHRBCGaIMR3EDV88XunA_pz9hpAO2BrMl39oxLT0RTvpF9vY5Ob</recordid><startdate>202207</startdate><enddate>202207</enddate><creator>Katada, Eiichi</creator><creator>Toyoda, Takanari</creator><creator>Yamada, Gohei</creator><creator>Morishima, Akira</creator><creator>Matsukawa, Noriyuki</creator><general>Wiley Subscription Services, Inc</general><general>John Wiley and Sons Inc</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>K9.</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-1594-5141</orcidid></search><sort><creationdate>202207</creationdate><title>A case of chronic inflammatory demyelinating polyneuropathy following COVID‐19 vaccine</title><author>Katada, Eiichi ; Toyoda, Takanari ; Yamada, Gohei ; Morishima, Akira ; Matsukawa, Noriyuki</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5054-249f73d31ca28e529b313dd97b3976cbb357ae7977bd0432a147cc15a66777473</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Ataxia</topic><topic>Case Report</topic><topic>chronic inflammatory demyelinating polyneuropathy</topic><topic>COVID-19</topic><topic>COVID‐19 vaccine</topic><topic>Demyelination</topic><topic>Guillain–Barrẻ syndrome</topic><topic>Inflammation</topic><topic>Paresthesia</topic><topic>Polyneuropathy</topic><topic>Vaccines</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Katada, Eiichi</creatorcontrib><creatorcontrib>Toyoda, Takanari</creatorcontrib><creatorcontrib>Yamada, Gohei</creatorcontrib><creatorcontrib>Morishima, Akira</creatorcontrib><creatorcontrib>Matsukawa, Noriyuki</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Neurology and clinical neuroscience</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Katada, Eiichi</au><au>Toyoda, Takanari</au><au>Yamada, Gohei</au><au>Morishima, Akira</au><au>Matsukawa, Noriyuki</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A case of chronic inflammatory demyelinating polyneuropathy following COVID‐19 vaccine</atitle><jtitle>Neurology and clinical neuroscience</jtitle><addtitle>Neurol Clin Neurosci</addtitle><date>2022-07</date><risdate>2022</risdate><volume>10</volume><issue>4</issue><spage>223</spage><epage>225</epage><pages>223-225</pages><issn>2049-4173</issn><eissn>2049-4173</eissn><abstract>We report a 44‐year‐old woman who presented with bilateral weakness of the hands and distal paresthesia of the arms on the next day of the second COVID‐19 vaccine, and gradually progressed ascending weakness of the arms and legs, and sensory ataxia beyond 2 months. She was diagnosed as a chronic inflammatory demyelinating polyneuropathy (CIDP) following COVID‐19 vaccine on the basis of clinical and electrophysiological findings. This is a first case diagnosed as a CIDP following COVID‐19 vaccine alone.</abstract><cop>England</cop><pub>Wiley Subscription Services, Inc</pub><pmid>35601443</pmid><doi>10.1111/ncn3.12604</doi><tpages>3</tpages><orcidid>https://orcid.org/0000-0002-1594-5141</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2049-4173
ispartof Neurology and clinical neuroscience, 2022-07, Vol.10 (4), p.223-225
issn 2049-4173
2049-4173
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9115276
source Wiley-Blackwell Read & Publish Collection
subjects Ataxia
Case Report
chronic inflammatory demyelinating polyneuropathy
COVID-19
COVID‐19 vaccine
Demyelination
Guillain–Barrẻ syndrome
Inflammation
Paresthesia
Polyneuropathy
Vaccines
title A case of chronic inflammatory demyelinating polyneuropathy following COVID‐19 vaccine
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T11%3A26%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20case%20of%20chronic%20inflammatory%20demyelinating%20polyneuropathy%20following%20COVID%E2%80%9019%20vaccine&rft.jtitle=Neurology%20and%20clinical%20neuroscience&rft.au=Katada,%20Eiichi&rft.date=2022-07&rft.volume=10&rft.issue=4&rft.spage=223&rft.epage=225&rft.pages=223-225&rft.issn=2049-4173&rft.eissn=2049-4173&rft_id=info:doi/10.1111/ncn3.12604&rft_dat=%3Cproquest_pubme%3E2685867607%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c5054-249f73d31ca28e529b313dd97b3976cbb357ae7977bd0432a147cc15a66777473%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2685867607&rft_id=info:pmid/35601443&rfr_iscdi=true